Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.73 USD | +3.02% |
|
0.00% | +90.91% |
25/06 | ChromaDex Chief Financial Officer Brianna Gerber to Resign | MT |
24/06 | ChromaDex Says Nicotinamide Riboside Shows 'Promising Effects' in Peripheral Artery Disease Trial | MT |
Business Summary
Number of employees: 106
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Consumer Products
83.2
%
| 60 | 83.4 % | 70 | 83.2 % | +15.67% |
Ingredients
13.3
%
| 9 | 12.1 % | 11 | 13.3 % | +27.48% |
Analytical Reference Standards and Services
3.5
%
| 3 | 4.4 % | 3 | 3.5 % | -9.33% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
70.1
%
| 50 | 69.8 % | 59 | 70.1 % | +16.50% |
International
29.9
%
| 22 | 30.2 % | 25 | 29.9 % | +14.68% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Robert Fried
CEO | Chief Executive Officer | 64 | 09/15/09 |
Frank Jaksch
FOU | Founder | 55 | 01/99/01 |
Brianna Gerber
DFI | Director of Finance/CFO | 44 | - |
David Kroes
HRO | Human Resources Officer | - | - |
Jason Campbell
PRN | Corporate Officer/Principal | - | - |
Trent Crane
SAM | Sales & Marketing | - | - |
Andrew Shao
LAW | General Counsel | - | 01/20/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Steven Rubin
BRD | Director/Board Member | 63 | 27/17/27 |
Hamed Shahbazi
BRD | Director/Board Member | 49 | 09/22/09 |
Frank Jaksch
FOU | Founder | 55 | 01/99/01 |
Robert Fried
CEO | Chief Executive Officer | 64 | 09/15/09 |
Kristin Patrick
BRD | Director/Board Member | 53 | 15/22/15 |
Wing Tak Yu
BRD | Director/Board Member | 48 | 18/17/18 |
Gary Ng
BRD | Director/Board Member | 52 | 13/21/13 |
Ann Cohen
BRD | Director/Board Member | 63 | 15/22/15 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 75,538,787 | 48,505,511 ( 64.21 %) | 0 | 64.21 % |
Company contact information
Chromadex Corp.
10900 Wilshire Boulevard Suite 600
90024, Los Angeles
+310 388 6706
http://www.chromadex.com![address ChromaDex Corporation(CDXC)](https://cdn.zonebourse.com/static/address/27343156.png)
Sector
Sales per Business
Sales per region
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+90.91% | 201M | |
+38.65% | 39.1B | |
-8.62% | 38.76B | |
+26.95% | 31.24B | |
+10.74% | 25.9B | |
-13.50% | 25.8B | |
+44.87% | 14.06B | |
+34.36% | 13.12B | |
-7.14% | 11.32B | |
-12.61% | 10.68B |
- Stock Market
- Equities
- CDXC Stock
- Company ChromaDex Corporation